QSI Quantum-Si incorporated
QSI Quantum-Si incorporated
Healthcare · Medical Devices
Desk view
Market read
POC $0.94 · VWAP $1.29 · -12.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, CFO + 1 other sold $39.4K, Sep 23
Coverage
1 watchlist
QSI Price Structure
Loading timeframes…
Peers
Every watchlist QSI belongs to, members best 30-day change first — QSI highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $344000, diluted EPS -$0.11, net income -$24M (SEC filing). Across the print the stock moved -1.4% (close before → first close after).
full note →Against street estimates
How QSI's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about QSI from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- Press Releases - Quantum-Si
- Investor Relations - Quantum-Si Incorporated
- Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement | MarketScreener UK
- Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update - Quantum-Si Incorporated
- QSI Stock - Quantum Si Incorporated Information
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
QSI research tape
12 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.